Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen

Physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) models can serve as a powerful framework for predicting the influence as well as the interaction of formulation, genetic polymorphism and co-medication on the pharmacokinetics and pharmacodynamics of drug substances. In this study, flur...

Full description

Bibliographic Details
Main Authors:	Ioannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Masoud Jamei, David Turner, Jennifer Dressman
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Series:	Pharmaceutics
Subjects:	physiologically based pharmacokinetic (PBPK) modeling pharmacokinetics/pharmacodynamics (PK/PD) <i>in vitro in vivo</i> extrapolation (IVIVE) mechanistic oral absorption modeling drug–drug interaction (DDI) pharmacogenetics
Online Access:	https://www.mdpi.com/1999-4923/12/11/1049

Similar Items

Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs
by: Hua He, et al.
Published: (2019-03-01)

Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human
by: Fen Yang, et al.
Published: (2017-10-01)

Implementation of Pharmacokinetic and Pharmacodynamic Strategies in Early Research Phases of Drug Discovery and Development at Novartis Institute of Biomedical Research
by: Tove eTuntland, et al.
Published: (2014-07-01)

Determination of Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Parameters of Doxycycline against <i>Edwardsiella ictaluri</i> in Yellow Catfish (<i>Pelteobagrus fulvidraco</i>)
by: Ning Xu, et al.
Published: (2021-03-01)

Pharmacokinetic and pharmacodynamic integration and modeling of enrofloxacin in swine for Escherichia coli
by: Jianyi eWang, et al.
Published: (2016-02-01)

Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
by: Lukas Kovar, et al.
Published: (2020-06-01)

Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
by: Huixi Zou, et al.
Published: (2020-07-01)

Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP)
by: Suein Choi, et al.
Published: (2019-07-01)

Pharmacokinetic-Pharmacodynamic Modeling to Study the Antipyretic Effect of Qingkailing Injection on Pyrexia Model Rats
by: Zhixin Zhang, et al.
Published: (2016-03-01)

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients
by: Lukas Kovar, et al.
Published: (2020-09-01)

Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds
by: Mohammad S. Alavijeh, et al.
Published: (2010-01-01)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020-10-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs
by: Zhixin Lei, et al.
Published: (2017-08-01)

Optimized design recommendation for first pharmacokinetic in vivo experiments for new tuberculosis drugs using pharmacometrics modelling and simulation
by: Leding, Albin
Published: (2021)

Evaluating Pharmacokinetic and Pharmacodynamic Interactions with Computational Models in Supporting Cumulative Risk Assessment
by: Jerry Campbell, et al.
Published: (2011-05-01)

Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
by: Hwang I, et al.
Published: (2020-10-01)

Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects
by: Kim CH, et al.
Published: (2017-12-01)

Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-clinical Mechanistic Assessment
by: Moorthy, Ganesh
Published: (2015)

Pharmacokinetics and pharmacodynamics of therapeutic antibodies in tumors and tumor-draining lymph nodes
by: Eric Salgado, et al.
Published: (2021-04-01)

Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats
by: Dong-Seok Lee, et al.
Published: (2018-04-01)

Dose optimisation based on pharmacokinetic/pharmacodynamic target of tigecycline
by: Bing Leng, et al.
Published: (2021-06-01)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
by: Xiaoxia eYang, et al.
Published: (2015-01-01)

Sulodexide. Pharmacokinetics, pharmacodynamics, and mechanism of action
by: Luca Masotti
Published: (2015-10-01)

Pharmacodynamics and pharmacokinetics of snake antivenom
by: Bhagya Nikapitiya, et al.
Published: (2018-06-01)

Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology
by: Sihem Ait-Oudhia, et al.
Published: (2014-03-01)

Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
by: Hsuan Ping Chang, et al.
Published: (2021-03-01)

Metabolism of IMM-H004 and Its Pharmacokinetic-Pharmacodynamic Analysis in Cerebral Ischemia/Reperfusion Injured Rats
by: Ziqian Zhang, et al.
Published: (2019-06-01)

Cefazolin in dog: preliminary results for pharmacokinetic and pharmacodynamic parameters
by: Federica Di Cesare
Published: (2016-06-01)

Pharmacokinetic- Pharmacodynamic Investigations of Letrozole, a Potential Novel Agent for the Treatment of High-Grade Gliomas
by: Arora, Priyanka
Published: (2019)

Pharmacokinetics, Pharmacodynamic Efficacy Prediction Indexes and Monte Carlo Simulations of Enrofloxacin Hydrochloride Against Bacterial Strains That Induce Common Clinical Diseases in Broiler Chickens
by: Karina P. D. Bonassa, et al.
Published: (2021-01-01)

Population pharmacokinetics and pharmacodynamics of pyronaridine
by: Methaneethorn, Janthima
Published: (2013)

A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators
by: Yiting Yang, et al.
Published: (2021-05-01)

Pharmacokinetic and pharmacodynamic profiling of generic amphotericin B colloidal dispersion in a rat model of invasive candidiasis
by: Huanhuan Qi, et al.
Published: (2020-12-01)

Pharmacokinetic profile and some pharmacodynamic aspects of cefquinome in chickens
by: A. A. M. El-Gendy, et al.
Published: (2009-12-01)

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
by: Bouazza Naïm, et al.
Published: (2011-12-01)

Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe
by: Bernard Ngara, et al.
Published: (2021-05-01)

PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUGS IN PATIENTS WITH RENAL DYSFUNCTION
by: K. Zakon, et al.
Published: (2017-12-01)

Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against Mycoplasma hyopneumoniae in an In Vitro Model
by: Huilin Zhang, et al.
Published: (2019-09-01)

Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model
by: Dongping Zeng, et al.
Published: (2018-05-01)

Cannot write session to /tmp/vufind_sessions/sess_hblurco7sinic1uf20sfuqvrh9